# EDGAR Filing Document

**Accession Number:** 0001142750
**File Stem:** 0001104659-26-054871
**Filing Date:** 2026-5
**Character Count:** 25863
**Document Hash:** c46d58c0ba42c0a08c9721da103fab31
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-054871.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0001104659-26-054871

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**EFFECTIVENESS DATE**: 20260504

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMN HEALTHCARE SERVICES INC
- **CENTRAL INDEX KEY:** 0001142750
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 061500476
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-295526
- **FILM NUMBER:** 26937525

**BUSINESS ADDRESS:**
- **STREET 1:** 2999 OLYMPUS BOULEVARD
- **STREET 2:** SUITE 500
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019
- **BUSINESS PHONE:** 8668718519

**MAIL ADDRESS:**
- **STREET 1:** 2999 OLYMPUS BOULEVARD
- **STREET 2:** SUITE 500
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75019

**As filed with the Securities and Exchange Commission on May 4, 2026**

**Registration No. 333-** 

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION** ****<br> Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT<br> UNDER<br> THE SECURITIES ACT OF 1933**

**AMN HEALTHCARE SERVICES, INC.** ****<br> (Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Delaware**<br> (State or other jurisdiction of<br> incorporation or organization) | &nbsp;&nbsp;**06-1500476**<br> (I.R.S. Employer<br> Identification No.) |
| &nbsp;&nbsp;**2999 Olympus Boulevard, Suite 500<br> Dallas, Texas**<br> (Address of Principal Executive Offices) | &nbsp;&nbsp;**75019**<br> (Zip Code) |

---

**AMN Healthcare 2025 Equity Plan**<br> (Full title of the plan)**

**Whitney M. Laughlin, Esq.<br> Chief Legal Officer and Corporate Secretary<br> AMN Healthcare Services, Inc.<br> 2999 Olympus Boulevard, Suite 500<br> Dallas, Texas 75019**

(Name and address of agent for service)

**(866) 871-8519**<br> (Telephone number, including area code, of agent for service)

***Copy to:*** **<br> Clinton W. Rancher<br> Baker Botts L.L.P.<br> 910 Louisiana Street<br> Houston, Texas 77002<br> (713) 229-1234**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer ¨ <br> Non-accelerated filer ¨ Smaller reporting company ¨ <br> Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ◻

**EXPLANATORY NOTE**

AMN Healthcare Services, Inc. (the "Company" or the "registrant") has prepared this Registration Statement on Form S-8 (this "Registration Statement") pursuant to General Instruction E of Form S-8 under the Securities Act of 1933, as amended, to register an additional 1,420,000 shares of the Company's common stock, par value $0.01 per share ("Common Stock"), issuable in respect of awards granted under the AMN Healthcare 2025 Equity Plan (as amended from time to time, the "Plan"). In accordance with General Instruction E to Form S-8, the contents of the Registration Statement on Form S-8 (Registration No. 333-286972) filed by the Company with the Securities and Exchange Commission (the "Commission") on [May 5, 2025](https://www.sec.gov/Archives/edgar/data/1142750/000110465925044510/tm2511981d1_s8.htm) relating to the Plan are incorporated by reference into this Registration Statement, except for those items being updated by this Registration Statement.

**PART II<br>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3.** **Incorporation of Documents by Reference.**

Except to the extent that information is deemed furnished and not filed pursuant to federal securities laws and regulations, the following documents filed with the Commission by the Company are incorporated by reference in this Registration Statement and will be deemed to be a part hereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Commission on [February 20, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/1142750/000162828026009918/amn-20251231.htm) (the "2025 Form 10-K");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the information included in the Company's Definitive Proxy Statement on Schedule 14A for the Company's 2026 Annual Meeting
of Shareholders, filed with the Commission on [March 18, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/1142750/000110465926029908/tm2524278-3_def14a.htm) , to the extent incorporated by reference in Part III of the 2025 Form 10-K;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the Company's Current Reports on Form 8-K, filed with the Commission on [February 5, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/1142750/000095014226000299/eh260734884_8k.htm) and [May 4, 2026](https://www.sec.gov/ix?doc=/Archives/edgar/data/1142750/000110465926054478/tm2613325d1_8k.htm) ;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the description of the Common Stock set forth in the Company's Registration Statement on Form 8-A, filed with the Commission
pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), on [October 26, 2001](https://www.sec.gov/Archives/edgar/data/1142750/000095014201500501/form8-a12b.txt) , as updated
by the description of the Common Stock set forth in [Exhibit 4.5](https://www.sec.gov/Archives/edgar/data/1142750/000114275023000006/amn-ex45x20221231x10k.htm) to the Company's Annual Report on Form 10-K for the fiscal year
ended December 31, 2022, filed with the Commission on [February 22, 2023](https://www.sec.gov/ix?doc=/Archives/edgar/data/1142750/000114275023000006/amn-20221231.htm) , as updated by the description of the Common Stock set forth in [Exhibit 4.1](https://www.sec.gov/Archives/edgar/data/1142750/000114275025000034/amn-ex41x20250331x10q.htm) to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on [May 9, 2025](https://www.sec.gov/Archives/edgar/data/1142750/000114275025000034/amn-20250331.htm) , and any subsequent amendment or report filed for the purpose of updating any such description.

Except to the extent that information is deemed furnished and not filed pursuant to federal securities laws and regulations, all reports and documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date hereof and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold, or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and made a part hereof from the date of the filing of such documents.

Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein and to be a part hereof shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 8.** **Exhibits.**

The following documents are filed as a part of this Registration Statement or incorporated by reference herein:

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| [4.1](https://www.sec.gov/Archives/edgar/data/1142750/000114275024000040/amn-ex31x20240331x10q.htm) | [Second Amended and Restated Certificate of Incorporation of AMN Healthcare Services, Inc. (incorporated by reference to Exhibit 3.1 of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, filed with the Commission on May 9, 2024).](https://www.sec.gov/Archives/edgar/data/1142750/000114275024000040/amn-ex31x20240331x10q.htm) |
| [4.2](https://www.sec.gov/Archives/edgar/data/1142750/000114275025000058/exhibit3112112025.htm) | [Amended and Restated By-laws of AMN Healthcare Services, Inc. dated December 11, 2025 (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K dated December 11, 2025, filed with the Commission on December 11, 2025).](https://www.sec.gov/Archives/edgar/data/1142750/000114275025000058/exhibit3112112025.htm) |
| [4.3](https://www.sec.gov/Archives/edgar/data/1142750/000093639202000259/a78565ex4-1.txt) | [Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2001, filed with the Commission on March 18, 2002).](https://www.sec.gov/Archives/edgar/data/1142750/000093639202000259/a78565ex4-1.txt) |
| [4.4](https://www.sec.gov/Archives/edgar/data/1142750/000110465925044363/tm2513592d1_ex10-1.htm) | [AMN Healthcare 2025 Equity Plan (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K dated May 2, 2025, filed with the Commission on May 5, 2025).](https://www.sec.gov/Archives/edgar/data/1142750/000110465925044363/tm2513592d1_ex10-1.htm) |
| [4.5](https://www.sec.gov/Archives/edgar/data/1142750/000110465926054478/tm2613325d1_ex10-1.htm) | [Amendment No. 1 to the AMN Healthcare 2025 Equity Plan (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K dated May 1, 2026, filed with the Commission on May 4, 2026).](https://www.sec.gov/Archives/edgar/data/1142750/000110465926054478/tm2613325d1_ex10-1.htm) |
| [5.1\*](tm2612697d1_ex5-1.htm) | [Opinion of Baker Botts L.L.P. as to the legality of the securities being registered.](tm2612697d1_ex5-1.htm) |
| [23.1\*](tm2612697d1_ex23-1.htm) | [Consent of KPMG LLP, independent registered public accounting firm.](tm2612697d1_ex23-1.htm) |
| [23.2\*](tm2612697d1_ex5-1.htm) | [Consent of Baker Botts L.L.P. (included in Exhibit 5.1).](tm2612697d1_ex5-1.htm) |
| [24.1\*](#a_001) | [Power of Attorney (included on signature pages hereto).](#a_001) |
| [107.1\*](tm2612697d1_ex-filingfees.htm) | [Filing Fee Table.](tm2612697d1_ex-filingfees.htm) |

---

\* Filed herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Dallas, State of Texas, on May 4, 2026.

---

| | |
|:---|:---|
| **AMN HEALTHCARE SERVICES, INC.** | **AMN HEALTHCARE SERVICES, INC.** |
| By: | /s/ Caroline S. Grace |
| Name: | Caroline S. Grace |
| Title: | President and Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below hereby constitutes and appoints each of Caroline S. Grace, Brian M. Scott and Whitney M. Laughlin, acting singly, his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment and (iv) take any and all actions which may be necessary or appropriate in connection therewith, granting unto such agents, proxies and attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact or any of their substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on May 4, 2026.

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Signature** | &nbsp;&nbsp; **Title** |
| &nbsp;&nbsp;/s/ Caroline S. Grace | &nbsp;&nbsp;President and Chief Executive Officer and Director<br> (Principal Executive Officer) |
| &nbsp;&nbsp;Caroline S. Grace | &nbsp;&nbsp;President and Chief Executive Officer and Director<br> (Principal Executive Officer) |
| &nbsp;&nbsp;/s/ Brian M. Scott | &nbsp;&nbsp;Chief Financial Officer and Chief Operating Officer<br> (Principal Financial Officer and Principal Accounting Officer) |
| &nbsp;&nbsp;Brian M. Scott | &nbsp;&nbsp;Chief Financial Officer and Chief Operating Officer<br> (Principal Financial Officer and Principal Accounting Officer) |
| &nbsp;&nbsp;/s/ Mark G. Foletta | &nbsp;&nbsp;Director and Chairman of the Board |
| &nbsp;&nbsp;Mark G. Foletta | &nbsp;&nbsp;Director and Chairman of the Board |
| &nbsp;&nbsp;/s/ Jorge A. Caballero | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Jorge A. Caballero | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ Teri G. Fontenot | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Teri G. Fontenot | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ James H. Hinton | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;James H. Hinton | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ Celia P. Huber | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Celia P. Huber | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ Daphne E. Jones | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Daphne E. Jones | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ Eric Palmer | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Eric Palmer | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;/s/ Sylvia Trent-Adams | &nbsp;&nbsp;Director |
| &nbsp;&nbsp;Sylvia Trent-Adams | &nbsp;&nbsp;Director |

---

## Exhibit 5.1

**Exhibit 5.1**

---

| | | | |
|:---|:---|:---|:---|
| ![](tm2612697d1_ex5-1img001.jpg) | 910 Louisiana Street<br> Houston, Texas<br> 77002-4995<br>TEL +1 713.229.1234<br> FAX +1 713.229.1522<br> BakerBotts.com | AUSTIN<br> BRUSSELS<br> DALLAS<br> DUBAI<br> **HOUSTON**<br> LONDON<br>| NEW YORK<br> PALO ALTO<br> RIYADH<br> SAN FRANCISCO<br> Singapore<br> WASHINGTON<br>|

---

May 4, 2026

AMN Healthcare Services, Inc.

2999 Olympus Boulevard, Suite 500

Dallas, Texas 75019

Ladies and Gentlemen:

As set forth in the Registration Statement on Form S-8 (the "Registration Statement") to be filed on the date hereof by AMN Healthcare Services, Inc., a Delaware corporation (the "Company"), with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Act"), relating to 1,420,000 shares (the "Shares") of common stock, par value $0.01 per share, of the Company (the "Common Stock") issuable in respect of awards granted under the AMN Healthcare 2025 Equity Plan (as amended from time to time, the "Plan"), certain legal matters in connection with the Shares subject to original issuance by the Company therewith are being passed upon for you by us. At your request, this opinion letter is being furnished to you for filing as Exhibit 5.1 to the Registration Statement.

In our capacity as your counsel in the connection referred to above, we have examined originals, or copies certified or otherwise identified, of (i) the Company's Second Amended and Restated Certificate of Incorporation and Amended and Restated By-laws, each as amended to date, (ii) the Plan, (iii) corporate records of the Company, including minute books of the Company, as furnished to us by the Company, (iv) certificates of public officials and of representatives of the Company, (v) the Registration Statement and (vi) statutes and other records, certificates, instruments and documents as we have deemed necessary or advisable as a basis for the opinions hereinafter expressed.

In making our examination, we have assumed, with your consent and without independent investigation or verification, the legal capacity and competency of all natural persons, that all signatures on documents examined by us are genuine, that all documents submitted to us as originals are authentic and complete, that all documents submitted to us as copies are true, correct and complete copies of the originals of such documents and that all information submitted to us is accurate and complete. We have also assumed, as to factual matters, with your consent and without independent investigation or verification, the truth and accuracy of the certificates, statements or other representations of officers or other representatives of the Company and of governmental and public officials. In addition, we have assumed for purposes of this opinion letter that (i) the Shares will be issued pursuant to the provisions of the Plan and any applicable award agreement (and any related instrument) duly adopted under and in accordance with the terms and conditions of the Plan (each, an "Award Agreement"); (ii) the consideration received by the Company for the Shares will not be less than the par value of the Shares; and (iii) at or prior to the time of the delivery of any Shares, the Registration Statement will be effective under the Act.

![](tm2612697d1_ex5-1img002.jpg)

 <br> AMN Healthcare Services, Inc. - 2 - May 4, 2026

On the basis of the foregoing, and subject to the assumptions, limitations and qualifications set forth herein, we are of the opinion that, in the case of Shares originally issued by the Company pursuant to the provisions of the Plan and any applicable Award Agreement, following due authorization of a particular award thereunder by the Board of Directors of the Company (the "Board"), the Talent and Compensation Committee of the Board or a similar committee of the Board (the Board or such committee, the "Administrator") as provided in and in accordance with the Plan and any applicable Award Agreement, the Shares issuable pursuant to such award will have been duly authorized by all necessary corporate action on the part of the Company. Upon issuance and delivery of such Shares from time to time pursuant to the terms of the Plan and such award, for the consideration established pursuant to the terms of the Plan and any applicable Award Agreement, and otherwise in accordance with the terms and conditions of such award, including, if applicable, the lapse of any restrictions relating thereto, the satisfaction of any performance conditions associated therewith and any requisite determinations by or pursuant to the authority of the Administrator as provided therein, and, in the case of stock options, the exercise thereof and payment for such Shares as provided therein, such Shares will be validly issued, fully paid and non-assessable.

The opinions set forth above in this opinion letter are limited to the original issuance of Shares by the Company and do not cover shares of Common Stock delivered by the Company out of shares reacquired by it.

The opinions set forth above in this opinion letter are limited in all respects to matters of the General Corporation Law of the State of Delaware, as in effect on the date hereof. We express no opinion as to the law of any other jurisdiction.

We hereby consent to the filing of this opinion letter with the Commission as Exhibit 5.1 to the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Baker Botts L.L.P. |

---

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the use of our reports dated February 19, 2026, with respect to the consolidated financial statements of AMN Healthcare Services, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.

/s/ KPMG LLP

San Diego, California

May 4, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **AMN HEALTHCARE SERVICES INC**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Type**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Class Title**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Calculation Rule**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount Registered**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Proposed Maximum Offering Price Per Unit**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Maximum Aggregate Offering Price**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Registration Fee**  |
| 1 | Equity | Common Stock, par value $0.01 per share | Other | 1420000 | $21.06 | $29905200.00 | 0.0001381 | $4129.91 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $29905200.00  |  | $4129.91  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $4129.91  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> Estimated in accordance with Rule 457(c) and Rule 457(h) under the Securities Act of 1933, as amended (the "Securities Act"), solely for purposes of calculating the registration fee, based on the average of the high and low sales prices of the common stock, par value $0.01 per share ("Common Stock"), of AMN Healthcare Services, Inc. as reported on the New York Stock Exchange on April 29, 2026. Represents shares of Common Stock issuable in respect of awards granted under the AMN Healthcare 2025 Equity Plan (as amended from time to time, the "Plan"), which includes shares of Common Stock that may again become available for delivery with respect to awards under the Plan pursuant to the share counting, share recycling and other terms and conditions of the Plan. Pursuant to Rule 416(a) under the Securities Act, this Registration Statement on Form S-8 shall also cover such indeterminate number of additional shares of Common Stock as may become issuable under the Plan as a result of stock splits, stock dividends, recapitalizations or similar transactions pursuant to the adjustment or antidilution provisions thereof.

---

| |
|:---|
| |
| **Rule 457(p)** |
| Fee Offset Claims |
| Fee Offset Sources |

---